Sun, Feb 1, 2015, 5:51 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • invbiotech invbiotech Sep 11, 2013 1:42 PM Flag

    9/5 theflyonthewall: Bernstein identifies CLDX as biotech takeover candidate

    Celldex, Seattle Genetics among biotech takeover candidates, says Bernstein

    Bernstein identifies Biomarin (BMRN), Seattle Genetics (SGEN), Incyte (INCY), Celldex (CLDX), Clovis (CLVS) , Achillion (ACHN) and Ariad (ARIA) as potential takeover targets. The firm thinks that Medivation (MDVN), Achillion, and Ariad have major upcoming catalysts that could enable their stocks to break out over the next 6-12 months. The firm's favorite stocks in the sector for the rest of the year are Medivation, Celgene (CELG), and Gilead (GILD).

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CLDX
21.42-0.53(-2.41%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gran Tierra Energy, Inc.
AMEXFri, Jan 30, 2015 4:01 PM EST
Hawaiian Holdings Inc.
NASDAQFri, Jan 30, 2015 4:00 PM EST